01 7Kalbitor
Main Therapeutic Indication : Genetic Disorders
Currency : USD
2019 Revenue in Millions : 44
2018 Revenue in Millions : 0
Growth (%) : N/A
Main Therapeutic Indication : Genetic Disorders
Currency : USD
2020 Revenue in Millions : 39
2019 Revenue in Millions : 45
Growth (%) : -13
Main Therapeutic Indication : Genetic Disorders
Currency : USD
2021 Revenue in Millions : 34
2020 Revenue in Millions : 37
Growth (%) : -2
Main Therapeutic Indication : Genetic Diseases
Currency : USD
2022 Revenue in Millions : 34
2021 Revenue in Millions : 34
Growth (%) : 0
Main Therapeutic Indication : Genetic Diseases
Currency : USD
2023 Revenue in Millions : 0
2022 Revenue in Millions : 34
Growth (%) : -100
Main Therapeutic Indication : Dermatology
Currency : USD
2016 Revenue in Millions : 52
2015 Revenue in Millions : Not Reported
Growth (%) : Not Reported
Main Therapeutic Indication : Dermatology
Currency : USD
2017 Revenue in Millions : 67
2016 Revenue in Millions : 52
Growth (%) : 29
LOOKING FOR A SUPPLIER?
